nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CYP2E1—Fingolimod—multiple sclerosis	0.194	0.433	CbGbCtD
Methotrimeprazine—CYP2D6—Fingolimod—multiple sclerosis	0.0925	0.207	CbGbCtD
Methotrimeprazine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0913	0.204	CbGbCtD
Methotrimeprazine—CYP2E1—Dexamethasone—multiple sclerosis	0.0473	0.106	CbGbCtD
Methotrimeprazine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0363	0.166	CbGeAlD
Methotrimeprazine—CYP2D6—Dexamethasone—multiple sclerosis	0.0226	0.0503	CbGbCtD
Methotrimeprazine—HTR2A—trigeminal nerve—multiple sclerosis	0.00954	0.0435	CbGeAlD
Methotrimeprazine—DRD1—nerve—multiple sclerosis	0.00894	0.0408	CbGeAlD
Methotrimeprazine—HTR2A—pons—multiple sclerosis	0.00672	0.0307	CbGeAlD
Methotrimeprazine—DRD2—nerve—multiple sclerosis	0.00528	0.0241	CbGeAlD
Methotrimeprazine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00526	0.024	CbGeAlD
Methotrimeprazine—HTR2A—pineal body—multiple sclerosis	0.00479	0.0219	CbGeAlD
Methotrimeprazine—HTR2A—peripheral nervous system—multiple sclerosis	0.00447	0.0204	CbGeAlD
Methotrimeprazine—DRD1—brainstem—multiple sclerosis	0.00384	0.0175	CbGeAlD
Methotrimeprazine—HTR2A—nerve—multiple sclerosis	0.00348	0.0159	CbGeAlD
Methotrimeprazine—DRD4—brain—multiple sclerosis	0.00305	0.0139	CbGeAlD
Methotrimeprazine—CHRM4—nervous system—multiple sclerosis	0.00302	0.0138	CbGeAlD
Methotrimeprazine—HTR2C—brainstem—multiple sclerosis	0.00298	0.0136	CbGeAlD
Methotrimeprazine—CHRM4—central nervous system—multiple sclerosis	0.00291	0.0133	CbGeAlD
Methotrimeprazine—DRD3—nervous system—multiple sclerosis	0.00281	0.0128	CbGeAlD
Methotrimeprazine—DRD3—central nervous system—multiple sclerosis	0.0027	0.0123	CbGeAlD
Methotrimeprazine—DRD5—nervous system—multiple sclerosis	0.00263	0.012	CbGeAlD
Methotrimeprazine—DRD5—central nervous system—multiple sclerosis	0.00253	0.0116	CbGeAlD
Methotrimeprazine—DRD1—midbrain—multiple sclerosis	0.00245	0.0112	CbGeAlD
Methotrimeprazine—CHRM5—nervous system—multiple sclerosis	0.00236	0.0108	CbGeAlD
Methotrimeprazine—ADRA1A—brainstem—multiple sclerosis	0.00231	0.0106	CbGeAlD
Methotrimeprazine—CHRM4—brain—multiple sclerosis	0.00231	0.0105	CbGeAlD
Methotrimeprazine—CHRM5—central nervous system—multiple sclerosis	0.00227	0.0104	CbGeAlD
Methotrimeprazine—DRD2—brainstem—multiple sclerosis	0.00227	0.0103	CbGeAlD
Methotrimeprazine—DRD2—retina—multiple sclerosis	0.00219	0.00998	CbGeAlD
Methotrimeprazine—ADRA1B—nervous system—multiple sclerosis	0.00216	0.00984	CbGeAlD
Methotrimeprazine—DRD3—brain—multiple sclerosis	0.00215	0.00979	CbGeAlD
Methotrimeprazine—ADRA1D—nervous system—multiple sclerosis	0.00211	0.00963	CbGeAlD
Methotrimeprazine—HTR2C—medulla oblongata—multiple sclerosis	0.00208	0.00949	CbGeAlD
Methotrimeprazine—ADRA1B—central nervous system—multiple sclerosis	0.00208	0.00948	CbGeAlD
Methotrimeprazine—ADRA1D—central nervous system—multiple sclerosis	0.00203	0.00927	CbGeAlD
Methotrimeprazine—DRD5—brain—multiple sclerosis	0.00201	0.00918	CbGeAlD
Methotrimeprazine—DRD1—nervous system—multiple sclerosis	0.00201	0.00918	CbGeAlD
Methotrimeprazine—DRD1—central nervous system—multiple sclerosis	0.00194	0.00883	CbGeAlD
Methotrimeprazine—HTR2C—midbrain—multiple sclerosis	0.0019	0.00867	CbGeAlD
Methotrimeprazine—HTR2C—spinal cord—multiple sclerosis	0.00185	0.00846	CbGeAlD
Methotrimeprazine—CHRM5—brain—multiple sclerosis	0.0018	0.00823	CbGeAlD
Methotrimeprazine—ADRA1B—brain—multiple sclerosis	0.00165	0.00752	CbGeAlD
Methotrimeprazine—CHRM2—nervous system—multiple sclerosis	0.00162	0.00739	CbGeAlD
Methotrimeprazine—ADRA1D—brain—multiple sclerosis	0.00161	0.00736	CbGeAlD
Methotrimeprazine—HTR2C—nervous system—multiple sclerosis	0.00156	0.00713	CbGeAlD
Methotrimeprazine—CHRM2—central nervous system—multiple sclerosis	0.00156	0.00712	CbGeAlD
Methotrimeprazine—ADRA2C—medulla oblongata—multiple sclerosis	0.00154	0.00701	CbGeAlD
Methotrimeprazine—DRD1—brain—multiple sclerosis	0.00154	0.00701	CbGeAlD
Methotrimeprazine—HTR2C—central nervous system—multiple sclerosis	0.0015	0.00686	CbGeAlD
Methotrimeprazine—HTR2A—brainstem—multiple sclerosis	0.0015	0.00682	CbGeAlD
Methotrimeprazine—CHRM1—nervous system—multiple sclerosis	0.00148	0.00673	CbGeAlD
Methotrimeprazine—DRD2—midbrain—multiple sclerosis	0.00144	0.00659	CbGeAlD
Methotrimeprazine—HTR2A—retina—multiple sclerosis	0.00144	0.00658	CbGeAlD
Methotrimeprazine—CHRM1—central nervous system—multiple sclerosis	0.00142	0.00648	CbGeAlD
Methotrimeprazine—ADRA2C—midbrain—multiple sclerosis	0.0014	0.00641	CbGeAlD
Methotrimeprazine—ADRA2C—spinal cord—multiple sclerosis	0.00137	0.00625	CbGeAlD
Methotrimeprazine—CYP2D6—brainstem—multiple sclerosis	0.00136	0.00622	CbGeAlD
Methotrimeprazine—CHRM3—nervous system—multiple sclerosis	0.00132	0.00602	CbGeAlD
Methotrimeprazine—CHRM3—central nervous system—multiple sclerosis	0.00127	0.0058	CbGeAlD
Methotrimeprazine—CHRM2—brain—multiple sclerosis	0.00124	0.00565	CbGeAlD
Methotrimeprazine—ADRA2A—medulla oblongata—multiple sclerosis	0.00123	0.0056	CbGeAlD
Methotrimeprazine—ADRA1A—nervous system—multiple sclerosis	0.00121	0.00553	CbGeAlD
Methotrimeprazine—CYP2E1—medulla oblongata—multiple sclerosis	0.0012	0.00547	CbGeAlD
Methotrimeprazine—HTR2C—brain—multiple sclerosis	0.00119	0.00545	CbGeAlD
Methotrimeprazine—DRD2—nervous system—multiple sclerosis	0.00119	0.00542	CbGeAlD
Methotrimeprazine—ADRA1A—central nervous system—multiple sclerosis	0.00117	0.00532	CbGeAlD
Methotrimeprazine—ADRA2C—nervous system—multiple sclerosis	0.00115	0.00527	CbGeAlD
Methotrimeprazine—DRD2—central nervous system—multiple sclerosis	0.00114	0.00522	CbGeAlD
Methotrimeprazine—ADRA1A—cerebellum—multiple sclerosis	0.00114	0.0052	CbGeAlD
Methotrimeprazine—CHRM1—brain—multiple sclerosis	0.00113	0.00514	CbGeAlD
Methotrimeprazine—ADRA2A—midbrain—multiple sclerosis	0.00112	0.00511	CbGeAlD
Methotrimeprazine—DRD2—cerebellum—multiple sclerosis	0.00112	0.0051	CbGeAlD
Methotrimeprazine—Ethopropazine—BCHE—multiple sclerosis	0.00111	0.284	CrCbGaD
Methotrimeprazine—ADRA2C—central nervous system—multiple sclerosis	0.00111	0.00507	CbGeAlD
Methotrimeprazine—ADRA2A—spinal cord—multiple sclerosis	0.00109	0.00499	CbGeAlD
Methotrimeprazine—ADRA2C—cerebellum—multiple sclerosis	0.00109	0.00496	CbGeAlD
Methotrimeprazine—CYP2E1—spinal cord—multiple sclerosis	0.00107	0.00488	CbGeAlD
Methotrimeprazine—HTR2A—medulla oblongata—multiple sclerosis	0.00104	0.00476	CbGeAlD
Methotrimeprazine—CHRM3—brain—multiple sclerosis	0.00101	0.0046	CbGeAlD
Methotrimeprazine—HTR2A—midbrain—multiple sclerosis	0.000953	0.00435	CbGeAlD
Methotrimeprazine—HRH1—nervous system—multiple sclerosis	0.000938	0.00428	CbGeAlD
Methotrimeprazine—HTR2A—spinal cord—multiple sclerosis	0.00093	0.00424	CbGeAlD
Methotrimeprazine—ADRA1A—brain—multiple sclerosis	0.000926	0.00423	CbGeAlD
Methotrimeprazine—ADRA2A—nervous system—multiple sclerosis	0.000921	0.0042	CbGeAlD
Methotrimeprazine—Triflupromazine—BCHE—multiple sclerosis	0.000912	0.232	CrCbGaD
Methotrimeprazine—DRD2—brain—multiple sclerosis	0.000908	0.00414	CbGeAlD
Methotrimeprazine—HRH1—central nervous system—multiple sclerosis	0.000903	0.00412	CbGeAlD
Methotrimeprazine—CYP2E1—nervous system—multiple sclerosis	0.000901	0.00411	CbGeAlD
Methotrimeprazine—ADRA2A—central nervous system—multiple sclerosis	0.000887	0.00405	CbGeAlD
Methotrimeprazine—ADRA2C—brain—multiple sclerosis	0.000883	0.00403	CbGeAlD
Methotrimeprazine—CYP2E1—central nervous system—multiple sclerosis	0.000868	0.00396	CbGeAlD
Methotrimeprazine—ADRA2A—cerebellum—multiple sclerosis	0.000867	0.00396	CbGeAlD
Methotrimeprazine—CYP2E1—cerebellum—multiple sclerosis	0.000848	0.00387	CbGeAlD
Methotrimeprazine—HTR2A—nervous system—multiple sclerosis	0.000784	0.00358	CbGeAlD
Methotrimeprazine—HTR2A—central nervous system—multiple sclerosis	0.000754	0.00344	CbGeAlD
Methotrimeprazine—HTR2A—cerebellum—multiple sclerosis	0.000737	0.00336	CbGeAlD
Methotrimeprazine—HRH1—brain—multiple sclerosis	0.000717	0.00327	CbGeAlD
Methotrimeprazine—CYP2D6—nervous system—multiple sclerosis	0.000714	0.00326	CbGeAlD
Methotrimeprazine—ADRA2A—brain—multiple sclerosis	0.000704	0.00321	CbGeAlD
Methotrimeprazine—CYP2E1—brain—multiple sclerosis	0.000689	0.00314	CbGeAlD
Methotrimeprazine—CYP2D6—central nervous system—multiple sclerosis	0.000687	0.00314	CbGeAlD
Methotrimeprazine—CYP2D6—cerebellum—multiple sclerosis	0.000672	0.00307	CbGeAlD
Methotrimeprazine—HTR2A—brain—multiple sclerosis	0.000599	0.00273	CbGeAlD
Methotrimeprazine—CYP2D6—brain—multiple sclerosis	0.000546	0.00249	CbGeAlD
Methotrimeprazine—Chlorpromazine—BCHE—multiple sclerosis	0.00044	0.112	CrCbGaD
Methotrimeprazine—Acepromazine—ALB—multiple sclerosis	0.000346	0.0882	CrCbGaD
Methotrimeprazine—Thioproperazine—ALB—multiple sclerosis	0.000339	0.0862	CrCbGaD
Methotrimeprazine—Pipotiazine—ALB—multiple sclerosis	0.000333	0.0848	CrCbGaD
Methotrimeprazine—Clomipramine—ALB—multiple sclerosis	0.000263	0.0671	CrCbGaD
Methotrimeprazine—Chlorpromazine—ALB—multiple sclerosis	0.000181	0.046	CrCbGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	2.38e-05	7.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	2.38e-05	7.24e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	2.38e-05	7.24e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	2.38e-05	7.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	2.38e-05	7.22e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	2.37e-05	7.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	2.37e-05	7.19e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	2.36e-05	7.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	2.35e-05	7.15e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	2.35e-05	7.13e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.34e-05	7.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	2.33e-05	7.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	2.33e-05	7.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—ALB—multiple sclerosis	2.32e-05	7.05e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	2.3e-05	7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	2.28e-05	6.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	2.27e-05	6.91e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	2.27e-05	6.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—POMC—multiple sclerosis	2.25e-05	6.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—APOE—multiple sclerosis	2.25e-05	6.83e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	2.24e-05	6.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	2.24e-05	6.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	2.24e-05	6.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	2.23e-05	6.78e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MYC—multiple sclerosis	2.23e-05	6.77e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TGFB1—multiple sclerosis	2.22e-05	6.75e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	2.21e-05	6.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	2.21e-05	6.72e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—APOE—multiple sclerosis	2.21e-05	6.72e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.21e-05	6.71e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—APOE—multiple sclerosis	2.21e-05	6.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	2.2e-05	6.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	2.2e-05	6.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	2.19e-05	6.67e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	2.19e-05	6.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	2.18e-05	6.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	2.18e-05	6.63e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MAPK1—multiple sclerosis	2.18e-05	6.62e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	2.17e-05	6.6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	2.17e-05	6.58e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	2.16e-05	6.58e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	2.14e-05	6.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	2.13e-05	6.47e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL2—multiple sclerosis	2.1e-05	6.39e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	2.09e-05	6.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	2.09e-05	6.37e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—IL6—multiple sclerosis	2.09e-05	6.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	2.08e-05	6.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	2.07e-05	6.3e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—POMC—multiple sclerosis	2.07e-05	6.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	2.06e-05	6.27e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—ALB—multiple sclerosis	2.05e-05	6.24e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	2.05e-05	6.23e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	2.04e-05	6.19e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CD80—multiple sclerosis	2.03e-05	6.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	2.02e-05	6.15e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	2.01e-05	6.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	2.01e-05	6.1e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	2e-05	6.08e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CD80—multiple sclerosis	2e-05	6.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.99e-05	6.05e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MMP9—multiple sclerosis	1.99e-05	6.04e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.98e-05	6.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.98e-05	6.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.97e-05	6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.96e-05	5.97e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	1.96e-05	5.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.96e-05	5.95e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.94e-05	5.91e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.93e-05	5.87e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.9e-05	5.78e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.9e-05	5.77e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.9e-05	5.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.89e-05	5.75e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL2—multiple sclerosis	1.89e-05	5.75e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.89e-05	5.75e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.89e-05	5.74e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.88e-05	5.73e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.88e-05	5.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	1.88e-05	5.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.88e-05	5.71e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.87e-05	5.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	1.87e-05	5.67e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.87e-05	5.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.86e-05	5.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.86e-05	5.66e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.86e-05	5.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	1.86e-05	5.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.86e-05	5.64e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.86e-05	5.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.85e-05	5.62e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.85e-05	5.62e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.84e-05	5.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.83e-05	5.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.82e-05	5.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.82e-05	5.53e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.82e-05	5.53e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.82e-05	5.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.81e-05	5.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.8e-05	5.48e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	1.79e-05	5.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.79e-05	5.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.78e-05	5.41e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—STAT3—multiple sclerosis	1.77e-05	5.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	1.77e-05	5.37e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	1.77e-05	5.37e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	1.74e-05	5.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.73e-05	5.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.73e-05	5.26e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.72e-05	5.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.69e-05	5.14e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.69e-05	5.13e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.68e-05	5.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.68e-05	5.12e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.68e-05	5.11e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.68e-05	5.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.67e-05	5.09e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL6—multiple sclerosis	1.67e-05	5.09e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.67e-05	5.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.66e-05	5.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.65e-05	5.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.65e-05	5.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MYC—multiple sclerosis	1.64e-05	4.99e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	1.64e-05	4.98e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	1.62e-05	4.93e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.62e-05	4.92e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	1.62e-05	4.91e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.61e-05	4.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	1.61e-05	4.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	1.59e-05	4.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	1.59e-05	4.84e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	1.59e-05	4.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	1.57e-05	4.78e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	1.57e-05	4.77e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	1.57e-05	4.77e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.57e-05	4.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	1.57e-05	4.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.55e-05	4.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	1.55e-05	4.71e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.55e-05	4.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	1.54e-05	4.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	1.54e-05	4.67e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	1.53e-05	4.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.52e-05	4.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	1.49e-05	4.53e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MYC—multiple sclerosis	1.48e-05	4.5e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	1.47e-05	4.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	1.47e-05	4.46e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MYC—multiple sclerosis	1.46e-05	4.44e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	1.46e-05	4.44e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	1.46e-05	4.42e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	1.46e-05	4.42e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	1.45e-05	4.4e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL2—multiple sclerosis	1.43e-05	4.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	1.43e-05	4.34e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	1.43e-05	4.34e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	1.42e-05	4.32e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	1.42e-05	4.31e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	1.4e-05	4.27e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL2—multiple sclerosis	1.4e-05	4.26e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	1.4e-05	4.25e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	1.4e-05	4.25e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	1.39e-05	4.24e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	1.39e-05	4.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	1.39e-05	4.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	1.39e-05	4.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	1.38e-05	4.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.38e-05	4.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	1.37e-05	4.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.37e-05	4.16e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	1.36e-05	4.14e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	1.35e-05	4.11e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.35e-05	4.1e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	1.33e-05	4.04e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOE—multiple sclerosis	1.33e-05	4.04e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	1.33e-05	4.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	1.32e-05	4.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	1.32e-05	4.02e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	1.32e-05	4.01e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	1.32e-05	4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	1.31e-05	3.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	1.31e-05	3.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	1.3e-05	3.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	1.3e-05	3.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	1.29e-05	3.92e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	1.28e-05	3.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	1.27e-05	3.87e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	1.26e-05	3.85e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	1.26e-05	3.84e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	1.24e-05	3.76e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—multiple sclerosis	1.23e-05	3.75e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	1.23e-05	3.74e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—multiple sclerosis	1.23e-05	3.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	1.23e-05	3.73e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	1.22e-05	3.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	1.21e-05	3.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	1.21e-05	3.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	1.21e-05	3.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	1.2e-05	3.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	1.2e-05	3.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	1.18e-05	3.6e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	1.18e-05	3.59e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	1.18e-05	3.59e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	1.18e-05	3.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	1.17e-05	3.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—multiple sclerosis	1.17e-05	3.55e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	1.16e-05	3.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	1.16e-05	3.52e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—POMC—multiple sclerosis	1.14e-05	3.47e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MYC—multiple sclerosis	1.12e-05	3.39e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	1.11e-05	3.39e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—multiple sclerosis	1.11e-05	3.38e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	1.1e-05	3.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	1.1e-05	3.33e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—multiple sclerosis	1.1e-05	3.33e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MYC—multiple sclerosis	1.1e-05	3.33e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	1.1e-05	3.33e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	1.09e-05	3.32e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	1.09e-05	3.32e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	1.09e-05	3.32e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.09e-05	3.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	1.09e-05	3.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	1.09e-05	3.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	1.08e-05	3.28e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	1.08e-05	3.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	1.08e-05	3.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	1.08e-05	3.27e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	1.07e-05	3.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	1.07e-05	3.26e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	1.07e-05	3.26e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.07e-05	3.25e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	1.07e-05	3.24e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	1.06e-05	3.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	1.05e-05	3.2e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—multiple sclerosis	1.04e-05	3.16e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	9.99e-06	3.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	9.97e-06	3.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	9.9e-06	3.01e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	9.78e-06	2.97e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	9.51e-06	2.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	9.25e-06	2.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	9.1e-06	2.77e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—multiple sclerosis	8.39e-06	2.55e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	8.26e-06	2.51e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—multiple sclerosis	8.24e-06	2.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	8.21e-06	2.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	8.19e-06	2.49e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	8.11e-06	2.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	8.08e-06	2.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	7.51e-06	2.28e-05	CbGpPWpGaD
